Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.40
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7383
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,607.22
    -445.55 (-0.46%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    0.00 (0.00%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6836
    -0.0007 (-0.10%)
     

Stocks in play: Arev Nanotec Brands Inc.

Announced that its 50% owned Joint Venture company, Absolem Mushroom Extraction Inc., a joint venture owned as to 50% AREV Brands and Absolem Health Inc. has engaged with Professor Robert Rogers to develop formulations and conduct research on certain functional medicinal mushrooms to be extracted by AREV Brands. Nanotechnology and AREV’s proprietary extraction systems are being utilized to develop new methods and product for the benefit of the Joint Venture. Robert Dale Rogers has been a herbalist for nearly fifty years and is a professional member of the American Herbalist Guild. From 1984 to 2002 he offered a clinical practice, helping support health decisions for over 20,000 clients. He teaches plant and mushroom medicine at Northern Star College, and is a clinical professor in family medicine at the University of Alberta, Canada. Arev Nanotec Brands Inc. shares C.AREV are trading off 1.56 percent at $0.32.

Read: